Anonymous
Guest
Anonymous
Guest
Such potential??? What were you saying about "dumb"???
I fail to see the potential of a niche device with no data to support it, an EXTREMELY small "save" rate, shrinking reimbursement, and no mention in any guidelines!
From the outside looking in, it seems there is a smaller group of patients that would likely benefit much more than others. ICD testing started first, before the clinical trial results proved benefit in a broader group patients. Here they seemed to have started broad, before proving it really worked well in a smaller subset.
I also do believe a wearable defibrillator is in the HRS guidelines.